Home > News > Nanogen Reports 2004 Third Quarter Results
November 3rd, 2004
Nanogen Reports 2004 Third Quarter Results
Nanogen, Inc. (Nasdaq: NGEN), developer of advanced diagnostic products, today announced its financial results for the third quarter ended September 30, 2004.
Total revenues for the third quarter of 2004 were $1.1 million compared to $1.7 million for the same period in 2003 and $1.1 million in the second quarter of 2004. Product revenues for the third quarter were $671,000 versus $752,000 for the same period in 2003 and were $477,000 in the second quarter of 2004.
Study finds long-term survival of human neural stem cells transplanted into primate brain April 23rd, 2014
High-Performance, Low-Cost Ultracapacitors Built with Graphene and Carbon Nanotubes: Future devices based on technology could bridge gap between batteries and conventional capacitors in portable electronics and hybrid electric vehicles April 23rd, 2014
Guo Lab Shows Potential of RNA as Heat-resistant Polymer Material for Nanoarchitectures April 23rd, 2014
National Space Society Congratulates SpaceX on the Success of CRS-3 and the First Flight of the Falcon 9R April 22nd, 2014
Nanometrics to Announce First Quarter Financial Results on April 29, 2014 April 9th, 2014
Acid folic was used in the production of the nanogel as targeting agent in drug delivery. The nanogel can be used in the treatment of cancer as a stable nanocarrier. Stability of nanocarriers is an important issue in target delivery mechanisms. Most of nanocarriers, due to their March 17th, 2014
Arrowhead Reports Fiscal 2014 First Quarter Financial Results - Conference Call Today at 4:30 p.m. Eastern Time February 4th, 2014
Arrowhead to Report Fiscal 2014 First Quarter Financial Results - Conference Call Scheduled for Tuesday, February 4, 2014 January 28th, 2014